Liver Injury Repair and Regeneration: Molecular Mechanisms and Therapeutic Targets
MedComm · 2026-11 · 7 (11)
DOI: 10.1002/mco2.71108 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 01.11.2026. Verfasst von Mingyue Pan und 15 weiteren Autor:innen. Beteiligte Einrichtung: School of Future Medicine Beijing University of Chinese Medicine Beijing China. Die Arbeit nennt 213 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
The liver possesses a remarkable regenerative capacity to restore tissue integrity and physiological function following acute injury. However, this endogenous repair potential is gradually impaired in chronic liver diseases, including metabolic dysfunction–associated steatohepatitis (MASH) and hepatic fibrosis. These disorders frequently lead to persistent inflammation and progressive hepatic dysfunction. Our incomplete understanding of the mechanisms behind pathological liver regeneration limits the development of new regenerative therapies. This review summarizes recent advances in liver regeneration across temporal, cellular, metabolic, and interorgan communication aspects. It describes the dynamic features of different regenerative phases and emphasizes the regulatory roles of non‐parenchymal cells within the regenerative niche. We also outline promising translational strategies, including molecular‐targeted therapy, cell‐based therapy, liver tissue engineering, and nanocarrier delivery systems. This review links basic mechanistic findings to clinical translation, discusses key existing research challenges, and offers useful insights for developing precision therapeutics for liver regeneration.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Future Medicine Beijing University of Chinese Medicine Beijing China.
- State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases Center of Advanced Pharmaceuticals and Biomaterials China Pharmaceutical University Nanjing China.
- Clinical Translational Science Center Beijing Tsinghua Changgung Hospital Tsinghua University Beijing China.
- Department of Biomedical Engineering School of Biomedical Engineering Tsinghua University Beijing China.
- Department of Hepatobiliary and Pancreatic Surgery General Surgery Center First Hospital of Jilin University Changchun China.
- School of Pharmacy Tongji Medical College Huazhong University of Science and Technology Wuhan China.
ORCID-Profile: Juan Liu
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Pan, M., An, N., Feng, Y., Hu, Y., Pan, C., Su, Y., Huang, Y., Long, T., Wang, Q., Song, Q., Li, P., Li, X., Yin, W., Hu, Z., Liu, X., & Liu, J. (2026). Liver Injury Repair and Regeneration: Molecular Mechanisms and Therapeutic Targets. MedComm, 7(11). https://doi.org/10.1002/mco2.71108
Vancouver
Pan M, An N, Feng Y, Hu Y, Pan C, Su Y, et al. Liver Injury Repair and Regeneration: Molecular Mechanisms and Therapeutic Targets. MedComm. 2026;7(11). doi:10.1002/mco2.71108
BibTeX
@article{Pan2026,
author = {Pan, Mingyue and An, Ni and Feng, Yutian and Hu, Yuelei and Pan, Chongqin and Su, Yuxin and Huang, Yuanzheng and Long, Tanqing and Wang, Qi and Song, Qingru and Li, Pengfei and Li, Xiaomeng and Yin, Wenzhen and Hu, Zhiyuan and Liu, Xiaoxuan and Liu, Juan},
title = {Liver Injury Repair and Regeneration: Molecular Mechanisms and Therapeutic Targets},
journal = {MedComm},
year = {2026},
volume = {7},
number = {11},
doi = {10.1002/mco2.71108}
}
EUVIMED